Protara Therapeutics Announces Third Quarter 2025 Financial Results and Provides Business Update
Provided By GlobeNewswire
Last update: Nov 10, 2025
NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA) (“Protara” or the “Company”), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced financial results for the third quarter ended September 30, 2025, and provided a business update.
Read more at globenewswire.com
